Methotrexate
Product manufactured by Mylan Pharmaceuticals Inc.
Indications and Purposes
| 1 Indications And Usage Methotrexate Tablets Are A Dihydrofolate Reductase Inhibitor Indicated For The: • Treatment Of Adults And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen ( 1.1 ) • Treatment Of Adults With Mycosis Fungoides ( 1.1 ) • Treatment Of Adults With Relapsed Or Refractory Non-Hodgkin Lymphoma As Part Of A Metronomic Combination Regimen ( 1.1 ) • Treatment Of Adults With Rheumatoid Arthritis ( 1.2 ) • Treatment Of Pediatric Patients With Polyarticular Juvenile Idiopathic Arthritis (Pjia) ( 1.3 ) • Treatment Of Adults With Severe Psoriasis ( 1.4 ) 1.1 Neoplastic Diseases Methotrexate Tablets Are Indicated For The: • Treatment Of Adults And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen . • Treatment Of Adults With Mycosis Fungoides (Cutaneous T-Cell Lymphoma) As A Single Agent Or As Part Of A Combination Chemotherapy Regimen . • Treatment Of Adults With Relapsed Or Refractory Non-Hodgkin Lymphomas As Part Of A Metronomic Combination Chemotherapy Regimen . 1.2 Rheumatoid Arthritis Methotrexate Tablets Are Indicated For The Treatment Of Adults With Rheumatoid Arthritis . 1.3 Polyarticular Juvenile Idiopathic Arthritis Methotrexate Tablets Are Indicated For The Treatment Of Pediatric Patients With Polyarticular Juvenile Idiopathic Arthritis (Pjia) . 1.4 Psoriasis Methotrexate Tablets Are Indicated For The Treatment Of Adults With Severe Psoriasis . |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Methotrexate Sodium |
|
ZINC1529323 |